Black Diamond Therapeutics, Inc. - Common Stock — キャッシュフロー (NASDAQ:BDTX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -52.15 M-100.15 M-85.08 M-66.72 M-62.3 M29.61 M -34.03 M 投資活動によるキャッシュフロー -281.69 M130.61 M53.37 M16.35 M16.97 M-44.91 M -33.95 M 財務活動によるキャッシュフロー 214.94 M729 K177 K71.93 M25.55 M-146 K -363 K フリーキャッシュフロー -52.15 M-100.15 M-85.08 M-66.72 M-62.3 M29.61 M -34.03 M

ニュース

BDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh Catalyst

Black Diamond Stock Outlook After Q1 Beat and Cash Runway

BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know

What's Going On With Black Diamond Therapeutics Stock Tuesday? - Black Diamond Therapeutic (NASDAQ:BDTX)

BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data

BDTX Shares Gain 11% in a Week: Here's What You Should Know

Implied Volatility Surging for Black Diamond Therapeutics Stock Options

BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize

BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right

Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026